<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>27</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">L. Tesolin</style></author></authors><translated-authors><author><style face="normal" font="default" size="100%">EDQM OCABR drafting group</style></author></translated-authors></contributors><titles><title><style face="normal" font="default" size="100%">Guideline for Pandemic COVID-19 Vaccine (Recombinant Spike Protein)</style></title></titles><keywords><keyword><style  face="normal" font="default" size="100%">COVID-19</style></keyword><keyword><style  face="normal" font="default" size="100%">OCABR</style></keyword><keyword><style  face="normal" font="default" size="100%">vaccine</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2021</style></year></dates><publisher><style face="normal" font="default" size="100%">EDQM</style></publisher><pub-location><style face="normal" font="default" size="100%">EDQM, strasbourg</style></pub-location><pages><style face="normal" font="default" size="100%">17</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><accession-num><style face="normal" font="default" size="100%">PA/PH/OMCL (21) 89 DEF</style></accession-num></record></records></xml>